Bulk drug major Aurobindo Pharma has proposed the sub-division of its equity shares, which at present have a face value of Rs 10 each.
The board of directors of the company is scheduled to meet on August 9 to finalise the share-split proposal. The company will then seek the shareholders nod at the ensuing annual general meeting on September 12.
